Dr. Ezekowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
830 Old Lancaster Rd
Ste 301
Bryn Mawr, PA 19010Phone+1 610-389-7626Fax+1 610-525-2114
Education & Training
- University of Cape Town Faculty of MedicineClass of 1970
Certifications & Licensure
- PA State Medical License 2000 - 2024
- CT State Medical License 1982 - 2002
- MD State Medical License 1977 - 1988
- OK State Medical License 1978 - 1988
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Efficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With Pacemakers Start of enrollment: 2006 Jul 01
- Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin Start of enrollment: 2008 Oct 01
Publications & Presentations
PubMed
- Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF.Linda S Johnson, Alexander P Benz, Ashkan Shoamanesh, John W Eikelboom, Michael Ezekowitz
Journal of the American Heart Association. 2024-09-03 - 1 citationsThe ATHERO-AF Study: A Need to Optimize AF Management in an Environment of Medical Advancement.Michael D Ezekowitz, Ibrahim Alameh, Mohammed Kamareddine
JACC. Advances. 2024-08-01 - 1 citationsEmergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry.Linda S Johnson, Yuxuan Jiang, Judy Luu, Isabelle C Van Gelder, Clare Atzema
European Heart Journal. 2024-07-09
Journal Articles
- Original Investigation Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients with Atrial FibrillationMichael Ezekowitz, MD, ScienceDirect
- Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients with Atrial FibrillationMichael Ezekowitz, MD, JACC: Cardiovascular Imaging
- Choosing a Particular Oral Anticoagulant and Dose for Stroke Prevention in Individual Patients with Non-Valvular Atrial Fibrillation: Part 1Jonathan L Halperin, Elaine M Hylek, Michael D Ezekowitz, James Aisenberg, European Heart Journal
Lectures
- Highlights in Anti-Coagulation2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- NOACs Post Cardioversion and Atrial Appendage Occlusion/Exclusion2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Engage @ACC.19 Studio: Cardiology Contest2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Press Mentions
- ESC: Apixaban Bests Heparin in Cardioversion TreatmentAugust 30th, 2017
- Merican Heart Association/American College of Physicians Ask Force on Clinical Competence and TrainingOctober 3rd, 2006
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: